Response to "Helping melanoma patients decide whether to choose adjuvant high-dose interferon-alpha 2b" - Reply Journal Article

  

Authors:	Hurley, K. E.; Chapman, P. B.
Article Title:	Response to "Helping melanoma patients decide whether to choose adjuvant high-dose interferon-alpha 2b" - Reply
Keywords:	cancer survival; interferon; drug megadose; follow up; letter; medical decision making; statistical significance
Journal Title:	The Oncologist
Volume:	11
Issue:	5
ISSN:	1083-7159
Publisher:	Oxford University Press
Date Published:	2006-05-01
Start Page:	539
End Page:	540
Language:	English
DOI:	10.1634/theoncologist.11-5-539
PROVIDER:	scopus
PUBMED:	16720861
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-33646861210&partnerID=40&md5=54aae9f2fc84578b3d5bcd75c2778c2c
Notes:	--- - "Export Date: 4 June 2012" - "CODEN: OCOLF" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/27446